Q3 FY2026
SFDC synced · Week 3 of Q3 · Last sync: 2 min ago
🔔
3
RL
Regional Lead
APJ Leadership
APJ Dashboard
Q3 FY2026 · All Regions · Week 3 of 13
⚠️
3 Forecast Drift Alerts require attention
Taiwan down 20% from Week 0 · India declined 3 consecutive weeks · Korea W1→W2 dip recovered. View Cadence →
Q3 Booking Forecast
$53.0M
▲ +$0.4M vs W2
APJ Total · All BUs
vs AOP Target
86%
$61.7M AOP for Q3
Net Bookings R&O
-$5.8M
▼ $3.2M risk exposure
Risks offset by $2.6M upside
Pipeline Cover
1.8x
▲ Healthy coverage ratio
Commit + Fcst + Upside
Booking Forecast vs AOP by Region
USD Millions · Q3 FY2026 · Week 3
Pipeline by Stage
APJ · All Regions
Regional R&O Summary — Week 3
Bookings Net R&O vs Forecast · USD Millions
RegionBooking Fcst (6+6)AOPAttainment Net RiskNet OppNet R&OStatus
R&O Weekly Input
India · Week 3 · Q3 FY2026
Booking & Revenue Forecast by BU
USD Millions — editable
Business UnitPrior Week BookingBooking FCST (6+6) ChangeRevenue FCST (6+6)
⚠️ Risks –$2.36M
#BUCustomerProduct LineProb USD'MPN#Updates
✅ Mitigations / Upside +$0.65M
#BUCustomerProduct LineProb USD'MPN#Updates
Deal Tracker
Full pipeline with stage progression history · 12 deals shown
PN#Account NameRegionBU StageAmount (USD)Close DateAge (days)Last Modified
Forecast Cadence
Week-over-week booking forecast tracking · Q3 FY2026
📉
Taiwan — Forecast Drift ↓20%
Dropped from $4.5M (W0) → $3.6M (W3). PN-2478842 timing risk flagged. Pharma 24 deal delayed.
⚠️
India — Declining 3 Weeks
$13.8M → $12.6M over 3 weeks (−8.7%). JSW Steel + IOL risks not fully offset.
🔄
Korea — Recovered W2→W3
Dipped to $8.1M in W2, recovered to $8.9M. FSI pull-in from MCS mitigated the risk.
Booking Forecast by Region — Week 0 to Week 3
USD Millions · Q3 FY2026
AOP Attainment Tracker
Current forecast vs Q3 AOP
Close Date Slippage — Deals Pushed Out of Q3
Opportunities that moved beyond Sep 30, 2026
PN#AccountRegionBUAmount Original CloseNew CloseSlippageReason
PN-2038440YoulChon Poseung KoreaPPA $145,000Sep 30, 2026Oct 31, 2026 +31 days PO timing / Purchasing hold
PN-2231125China Steel Co TaiwanPPA $50,000Aug 31, 2026Oct 15, 2026 +45 days Site visit pending — Samy
PN-2483704SK Energy KoreaEPM $140,000Sep 15, 2026Nov 30, 2026 +76 days Competitor negotiation ongoing
🎯 Leadership View
APJ CAD Division · Q3 FY2026 · Executive Pulse · Week 3 of 13
⚠️ AMBER
Will we make Q3? — At Risk
APJ booking forecast $53.0M vs $61.7M AOP target · Gap of –$8.7M (14%) · 4 of 6 regions on declining or flat trajectory · 2 swing deals totalling $2.3M in non-Commit stages · Funnel cover at 1.8x vs 2.5x target
⚡ 2 Swing Deals at Risk 📉 India –3 weeks consecutive 🕐 Taiwan –20% from W0 ✅ Japan trending up ✅ ANZ on track
Booking vs AOP
86%
▼ –$8.7M gap
$53.0M of $61.7M
Organic Growth %
+4.2%
Target: +6.0%
FX-neutral growth rate
Funnel Cover
1.8x
▼ Below 2.5x target
Need $43M more pipeline
LDO Pipeline ($200K+)
8
▲ $4.3M value
6 regions contributing
Net R&O Exposure
–$1.6M
▼ Risk > Upside
$8.5M risk · $6.9M upside
Funnel Cover by Region
Traffic light · 🟢 ≥2.5x · 🟡 1.5–2.5x · 🔴 <1.5x
Organic Growth % by Region
FX-neutral · Target line at 6%
⚡ Swing Deals at Risk
Deals ≥$500K in non-Won/Commit stages — can swing the quarter
PN#AccountRegBUStageAmountCloseRisk Flag
🏷️ LDO Pipeline ($200K+)
Large Deal Orders by region — APJ $200K threshold
Region# LDOsTotal ValueStage Mix
Week-over-Week R&O Movement
Booking forecast change W2 → W3 per region · What moved this week
RegionW2 FcstW3 FcstChangeNet R&OKey MovementAction Needed
India $12.9M$12.6M ▼ –$0.3M –$1.71M JSW Steel + IOL risks not offset. Weir Minerals BOM approval pending. 🔴 Escalate Weir BOM approval
Japan $15.0M$15.2M ▲ +$0.2M +$0.20M Life Tech pull-in progressing. MCS run-rate strong via channel. 🟢 On track — monitor only
Korea $8.6M$8.9M ▲ +$0.3M –$0.73M FSI pull-in from MCS recovered dip. POSCO Pohang progressing. 🟡 Watch SK Energy slippage
ANZ $4.4M$4.6M ▲ +$0.2M +$0.49M Upside converting. University of Adelaide cancelled offset by new pipeline. 🟢 Positive trajectory
SEA $8.0M$8.1M ▲ +$0.1M –$0.30M Malaysia Coast Guard Forecast steady. AERB compliance pending for 2 deals. 🟡 Compliance cert check needed
Taiwan $3.7M$3.6M ▼ –$0.1M –$1.25M Johnson Chemical Pharma still in Forecast. China Steel slipped to Oct. 🔴 Push Johnson Chem to Commit or de-risk
Revenue Shippable Backlog
Safe = CRD confirmed + factory slot available · Risky = CRD unreliable or slot gap
Key Management Questions
What leadership needs answered this week
🔴 Which region needs urgent attention?
India & Taiwan — both declining consecutively. India down $1.2M from W0 with $2.36M risk exposure. Taiwan down 20% from W0; Johnson Chemical Pharma ($941K) must move to Commit or be de-risked before W5.
🟢 What can still be pulled in to close the gap?
$3.4M identified upside: Rain Cement + BAEC PPA India ($0.30M), Japan Life Tech pull-in ($0.50M), ANZ pipeline converting ($1.59M upside), Korea FSI MCS ($0.80M). Needs acceleration by W8.
🔵 Which swing deals can flip the quarter?
Johnson Chemical Pharma $941K (Taiwan, Forecast) and Life Technologies Japan $500K (Japan, Forecast) — combined $1.4M could meaningfully close the OG% gap if both land in Q3.
✅ R&O submitted for India — Week 3